These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Zacks Open on Zacks
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure helps cut through all the noise.

The earnings figure itself is key, of course, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa.

Now that we know how important earnings and earnings surprises are, it's time to show investors how to take advantage of these events to boost their returns by utilizing the Zacks Earnings ESP filter.

The Zacks Earnings ESP, Explained

The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate.

Now that we understand the basic idea, let's look at how the Expected Surprise Prediction works. The ESP is calculated by comparing the Most Accurate Estimate to the Zacks Consensus Estimate, with the percentage difference between the two giving us the Zacks ESP figure.

In fact, when we combined a Zacks Rank #3 (Hold) or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time. Perhaps most importantly, using these parameters has helped produce 28.3% annual returns on average, according to our 10 year backtest.

Most stocks, about 60%, fall into the #3 (Hold) category, and they are expected to perform in-line with the broader market. Stocks with a #2 (Buy) and #1 (Strong Buy) rating, or the top 15% and top 5% of stocks, respectively, should outperform the market, with Strong Buy stocks outperforming more than any other rank.

Should You Consider Tenet Healthcare?

The final step today is to look at a stock that meets our ESP qualifications. Tenet Healthcare (THC) earns a #3 (Hold) 29 days from its next quarterly earnings release on April 30, 2026, and its Most Accurate Estimate comes in at $4.21 a share.

By taking the percentage difference between the $4.21 Most Accurate Estimate and the $4.19 Zacks Consensus Estimate, Tenet Healthcare has an Earnings ESP of +0.44%. Investors should also know that THC is one of a large group of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

THC is one of just a large database of Medical stocks with positive ESPs. Another solid-looking stock is United Therapeutics (UTHR).

Slated to report earnings on April 29, 2026, United Therapeutics holds a #3 (Hold) ranking on the Zacks Rank, and its Most Accurate Estimate is $6.77 a share 28 days from its next quarterly update.

For United Therapeutics, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $6.72 is +0.74%.

Because both stocks hold a positive Earnings ESP, THC and UTHR could potentially post earnings beats in their next reports.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>

Should You Invest in Tenet Healthcare Corporation (THC)?

Before you invest in Tenet Healthcare Corporation (THC), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Tenet Healthcare Corporation (THC): Free Stock Analysis Report
 
United Therapeutics Corporation (UTHR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research